REISSUE OF NERVE AGENT ANTIDOTES

File: aaaap_02.txt
Page: 02
Total Pages: 2
PAAUZYUW RHFQAAA2545 2851238-UUBB--RHDIBFF.
ZNR UUUBB
P 121700Z OCT 90
FM HQ USAFE RAMSTEIN AB GE//SGAL//
TO AIG 8157//SGL//
RBDOXR/310USAFCONTHOSP NOCTON HALL RAF WADDINGTON UK//SGL//
INFO RHDIAAA/USCENTAF REAR LANGLEY AFB VA//BSD//
RUVKBRK/HQ AFOMS BROOKS AFB TX//SGSL//
RUEORDC/AFMLO FT DETRICK MD//FOR//
BT
UNCLAS (RELEASABLE TO NATO AS NATO UNCLAS)
SUBJ: REISSUE OF NERVE AGENT ANTIDOTES
1.  USCENTAF REAR/BSD MESSAGE 100019Z OCT 90, SAME SUBJECT (NOT TO AFOMS OR AFMLO) INDICATES THAT AGENT ANTIDOTES HAVE A GREATLY REDUCED SHELF LIFE WHCRQREMOVED FROM CONTROLLED STORAGE CONDITIONS.
USCENTAF REAR RECOMMENDS THAT ALL RETURNED NERVE AGENT ANTIDOTES (ATROPINE AND PRALIDOXIME AUTOINJECTORS AND PYRIDOSTIGMINE TABLETS) NOT BE REISSUED EXCEPT IN EMERGENCIES  AND THAT ALL NEWLY DEPLOYING PERSONNEL BE ISSUED FRESH ANTIDOTES FROM THE SUPPORTING LOCAL BASE MEDICAL SUPPLY ACCOUNT.
2. THE FOLLOWING GUIDANCE APPLIES TO ALL USAFE MEDICAL LOGISTICS ACTIVIVITIES:


PAGE2  RHFQAAA2545 UNCLAS (RELEASABLE TO NATO AS NATO UNCLAS)
A.  NERVE AGENT ANTIDOTES RETURNED BY DEPLOYED PERSONNEL WILL BE CONSIDERED UNSERVICEABLE.
B.  MEDICAL SUPPLY WILL PROCESS NONREIMBURSABLE (NO CREDIT) TURN-INS INTO WRM SUSPENDED INVENTORY CATEGORY FOR ALL RETURNED ANTIDOTES.
C.  MAINTAIN THESE ASSETS ON HAND AS SUSPENDED STOCK PENDING DISPOSITION INSTRUCTIONS FROM THIS HEADQUARTERS.

[(b)(6)]

BT
#2545
NNNN

PRIORITY    						PAGE: 1